Tiziana Life Sciences Ltd ( TLSA) - Key Metrics
TLSA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$0.22 | -$0.10 | -$0.10 |
| 2025Q2 | $0 | -$0.10 | -$0.12 | -$0.12 |
| 2024Q4 | $0 | -$0.13 | -$0.03 | -$0.03 |
| 2024Q2 | $0 | -$0.18 | $0.01 | $0.01 |
| 2023Q4 | $0 | -$0.18 | -$0.07 | -$0.07 |
TLSA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -1.69 |
| 2025Q2 | 0% | -4.10 |
| 2024Q4 | 0% | -1.32 |
| 2024Q2 | 0% | -1.23 |
| 2023Q4 | 0% | -0.79 |
TLSA
Price: $1.11
52 week price:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 67400
Market Capitalization: 68.1 million